OPRD1
Delta-type opioid receptor
Also known as: OPRD_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P41143
- Gene
- OPRD1
- Ensembl
- ENSG00000116329
- Chromosome
- 1
- Canonical length
- 372 aa
- Protein class
- FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Enables G protein-coupled enkephalin receptor activity. Involved in several processes, including G protein-coupled opioid receptor signaling pathway; cellular response to hypoxia; and positive regulation of peptidyl-serine phosphorylation. Located in plasma membrane. Implicated in alcohol dependence; alcohol use disorder; drug dependence (multiple); opioid abuse; and withdrawal disorder. Biomarker of opioid abuse. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
372 residues, UniProt reviewed canonical sequence.
>P41143|OPRD1
1 MEPAPSAGAE LQPPLFANAS DAYPSACPSA GANASGPPGA RSASSLALAI AITALYSAVC
61 AVGLLGNVLV MFGIVRYTKM KTATNIYIFN LALADALATS TLPFQSAKYL METWPFGELL
121 CKAVLSIDYY NMFTSIFTLT MMSVDRYIAV CHPVKALDFR TPAKAKLINI CIWVLASGVG
181 VPIMVMAVTR PRDGAVVCML QFPSPSWYWD TVTKICVFLF AFVVPILIIT VCYGLMLLRL
241 RSVRLLSGSK EKDRSLRRIT RMVLVVVGAF VVCWAPIHIF VIVWTLVDID RRDPLVVAAL
301 HLCIALGYAN SSLNPVLYAF LDENFKRCFR QLCRKPCGRP DPSSFSRARE ATARERVTAC
361 TPSDGPGGGA AALocalizationUniProt · AlphaFold · HPA
Whether an antibody against OPRD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.33
- Highest tissue expression
- 2.7 nTPM
Expression across tissuesHPA
Tissue
- cerebral cortex: 2.7 nTPM
- basal ganglia: 1.4 nTPM
- hippocampal formation: 0.9 nTPM
- skeletal muscle: 0.9 nTPM
- amygdala: 0.8 nTPM
- adrenal gland: 0.5 nTPM
Single-cell type
- other brain neurons: 28 nCPM
- adrenal medulla cells: 21 nCPM
- brain inhibitory neurons: 18 nCPM
- brain excitatory neurons: 17 nCPM
- pancreatic islet cells: 9.3 nCPM
- retinal bipolar cells: 8.8 nCPM
Immune cell
- basophil: 0.8 nTPM
- neutrophil: 0.4 nTPM
- NK-cell: 0.2 nTPM
- plasmacytoid DC: 0.2 nTPM
- eosinophil: 0.1 nTPM
- memory B-cell: 0.1 nTPM
Brain region
- pons: 18 nTPM
- cerebral cortex: 15 nTPM
- hippocampal formation: 11 nTPM
- basal ganglia: 10 nTPM
- amygdala: 10 nTPM
- white matter: 9.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- gnomAD missense Z
- 1.58
- DepMap mean gene effect
- 0.07
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
- adult locomotory behavior
- cellular response to growth factor stimulus
- cellular response to hypoxia
- cellular response to toxic substance
- eating behavior
- G protein-coupled opioid receptor signaling pathway
- G protein-coupled receptor signaling pathway
- G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
- immune response
- negative regulation of gene expression
- negative regulation of protein-containing complex assembly
- neuropeptide signaling pathway
- phospholipase C-activating G protein-coupled receptor signaling pathway
- regulation of calcium ion transport
- regulation of mitochondrial membrane potential
- response to ethanol
- response to nicotine
Molecular functions
- G protein-coupled opioid receptor activity
- neuropeptide binding
- receptor serine/threonine kinase binding
- G protein-coupled enkephalin receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OPRD1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OPRD1 as an antibody target. Whether an autoantibody or antibody against OPRD1 could matter depends on whether native OPRD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OPRD1 is annotated at the cell surface, where native OPRD1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OPRD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...